Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

8.080 +0.020 (+0.25%)
Streaming Delayed Price Updated: 12:34 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,167,807
Open 8.000
Bid (Size) 8.080 (12)
Ask (Size) 8.090 (8)
Prev. Close 8.060
Today's Range 7.955 - 8.190
52wk Range 3.532 - 23.86
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
To gain an edge, this is what you need to know today. 
Via Benzinga
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 
Via Investor's Business Daily
Topics Government
Exposures Political

Performance

YTD
+60.64%
+60.64%
1 Month
-20.32%
-20.32%
3 Month
-37.56%
-37.56%
6 Month
-48.54%
-48.54%
1 Year
+51.03%
+51.03%

More News

Read More
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
Via Benzinga
Topics Government
Exposures Political
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Outlook For Novavax
Via Benzinga
Looking Into Novavax's Recent Short Interest
Via Benzinga
How Is The Market Feeling About Novavax?
Via Benzinga
US Stocks Likely To Open In Red After Jerome Powell Says No Need To Be 'In A Hurry' On Rate Cuts: Tesla, TSMC And Domino's In Focus
Via Benzinga
Topics Economy
Exposures Economy Interest Rates
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
Via Benzinga
Topics Government
Exposures Political
Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls
Via Benzinga
Exposures Product Safety
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
Via Benzinga
Exposures Product Safety
Smaller Cap Biotechs Are In Season: How Are We Doing?
Via Talk Markets
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
Via Benzinga
Exposures COVID-19
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
Via The Motley Fool
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
Via The Motley Fool
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
How Bad Is This News for Novavax?
Via The Motley Fool
Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Moves Higher; Morgan Stanley Profit Beats Estimates
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
What's Going On With Novavax Stock Today?
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.